Casciano F, Zauli E, Busin M, Caruso L, AlMesfer S, Al-Swailem S
Cancers (Basel). 2023; 15(14).
PMID: 37509256
PMC: 10377487.
DOI: 10.3390/cancers15143593.
Srdanovic S, Wolter M, Trinh C, Ottmann C, Warriner S, Wilson A
FEBS J. 2022; 289(17):5341-5358.
PMID: 35286747
PMC: 9541495.
DOI: 10.1111/febs.16433.
Wang B, Rasmussen-Ivey C, Little J, Yuan Z
Transl Cancer Res. 2022; 9(3):1993-1997.
PMID: 35117546
PMC: 8797865.
DOI: 10.21037/tcr.2019.12.89.
Nagpal I, Yuan Z
Front Cell Dev Biol. 2021; 9:775312.
PMID: 34888311
PMC: 8650216.
DOI: 10.3389/fcell.2021.775312.
Cui D, Qu R, Liu D, Xiong X, Liang T, Zhao Y
Front Cell Dev Biol. 2021; 9:775507.
PMID: 34869377
PMC: 8638743.
DOI: 10.3389/fcell.2021.775507.
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer.
Martens-Uzunova E, Kusuma G, Crucitta S, Lim H, Cooper C, Riches J
J Extracell Vesicles. 2021; 10(10):e12136.
PMID: 34434533
PMC: 8374107.
DOI: 10.1002/jev2.12136.
Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells-Relevance for Understanding (Germ Cell) Tumorigenesis.
Timmerman D, Remmers T, Hillenius S, Looijenga L
Int J Mol Sci. 2021; 22(10).
PMID: 34065345
PMC: 8161298.
DOI: 10.3390/ijms22105377.
Regulation of p53 by the 14-3-3 protein interaction network: new opportunities for drug discovery in cancer.
Falcicchio M, Ward J, Macip S, Doveston R
Cell Death Discov. 2020; 6(1):126.
PMID: 33298896
PMC: 7669891.
DOI: 10.1038/s41420-020-00362-3.
Zinc in the Brain: Friend or Foe?.
Choi S, Hong D, Choi B, Suh S
Int J Mol Sci. 2020; 21(23).
PMID: 33255662
PMC: 7728061.
DOI: 10.3390/ijms21238941.
Mdm2: Open questions.
Dobbelstein M, Levine A
Cancer Sci. 2020; 111(7):2203-2211.
PMID: 32335977
PMC: 7385351.
DOI: 10.1111/cas.14433.
DNA damage response manages cell cycle restriction of senile multipotent mesenchymal stromal cells.
Yao L, Yu F, Xu Y, Wang Y, Zuo Y, Wang C
Mol Biol Rep. 2019; 47(1):809-818.
PMID: 31664596
DOI: 10.1007/s11033-019-05150-6.
The PTEN Tumor Suppressor Gene in Soft Tissue Sarcoma.
Stefano S, Giovanni S
Cancers (Basel). 2019; 11(8).
PMID: 31416195
PMC: 6721622.
DOI: 10.3390/cancers11081169.
The long and the short of it: the MDM4 tail so far.
Haupt S, Mejia-Hernandez J, Vijayakumaran R, Keam S, Haupt Y
J Mol Cell Biol. 2019; 11(3):231-244.
PMID: 30689920
PMC: 6478121.
DOI: 10.1093/jmcb/mjz007.
MDMX under stress: the MDMX-MDM2 complex as stress signals hub.
de Polo A, Vivekanandan V, Little J, Yuan Z
Transl Cancer Res. 2018; 5(6):725-732.
PMID: 30319942
PMC: 6178224.
DOI: 10.21037/tcr.2016.12.18.
The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding.
Madigan J, Hou F, Ye L, Hu J, Dong A, Tempel W
J Biol Chem. 2018; 293(42):16142-16159.
PMID: 30143532
PMC: 6200923.
DOI: 10.1074/jbc.RA118.003525.
PTEN: Tumor Suppressor and Metabolic Regulator.
Chen C, Chen J, He L, Stiles B
Front Endocrinol (Lausanne). 2018; 9:338.
PMID: 30038596
PMC: 6046409.
DOI: 10.3389/fendo.2018.00338.
The Role of MDM2 in Promoting Genome Stability versus Instability.
Saadatzadeh M, Elmi A, Pandya P, Bijangi-Vishehsaraei K, Ding J, Stamatkin C
Int J Mol Sci. 2017; 18(10).
PMID: 29065514
PMC: 5666895.
DOI: 10.3390/ijms18102216.
AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.
de Polo A, Luo Z, Gerarduzzi C, Chen X, Little J, Yuan Z
J Mol Cell Biol. 2016; 9(2):154-165.
PMID: 27927748
PMC: 5907837.
DOI: 10.1093/jmcb/mjw045.
Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE.
Gerarduzzi C, de Polo A, Liu X, El Kharbili M, Little J, Yuan Z
J Biol Chem. 2016; 291(50):25937-25949.
PMID: 27777309
PMC: 5207067.
DOI: 10.1074/jbc.M116.752303.
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.
Marine J, Jochemsen A
Cold Spring Harb Perspect Med. 2016; 6(7).
PMID: 27371671
PMC: 4930919.
DOI: 10.1101/cshperspect.a026237.